Le Lézard
Classified in: Health, Business
Subjects: CXP, MAT

Face Forward Medical Aesthetics at Luminous Offers GAINSWave in New Jersey


NEW PROVIDENCE, N.J., March 12, 2018 /PRNewswire/ -- Face Forward Medical Aesthetics at Luminous is pleased to announce they now offer GAINSWavetm ! This breakthrough noninvasive medical therapy uses low-intensity shockwave therapy to enhance sexual performance and to treat Erectile Dysfunction symptoms.

GAINSWave Logo (PRNewsfoto/GAINSWave)

As men age, the vessels in their penis weaken, contract and fill with micro-plaque, which can lead to Erectile Dysfunction. As these tiny vessels become clogged, the penis decreases in sensitivity, making it harder for men to achieve and maintain an erection. Thankfully, the GAINSWavetm protocols can enhance a man's performance by using high-frequency acoustic waves to repair existing blood vessels and improve blood flow.

Thanks to the numerous clinical studies on Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT), we can see that this therapy improves not only erectile dysfunction symptoms but also sexual performance. "GAINSWavetm is an ideal solution for men looking to improve spontaneous erections without the use of Viagra or Cialis," says Richard Maggio, MD. Patients receiving GAINSWave therapy have reported improved erection quality, enhanced sexual performance and decreased refractory times between orgasms, which is why this a great alternative to ED medications.

This drug and surgery-free procedure only takes about 20 minutes and can enhance a man's sex life while addressing the root cause of Erectile Dysfunction. Face Forward Medical Aesthetics at Luminous is now treating men with the GAINSWavetm Therapy in their offices located at 598 Central Ave, New Providence, NJ 07974.

Dr. Rich, as he likes to be called, has been practicing as a board-certified Urological Surgeon for over 30 years. He attended medical school at New York Medical College and did his residency at NYU Medical Center. Since then he has been in private practice. Dr. Maggio has been using the most advanced and innovative techniques to help people look and feel younger. Being a Surgeon is extremely valuable when considering doing any facial enhancements. His extensive use with Injectables like Dysport, Restylane & Sculptra makes him a leader in the Industry. His knowledge with some of the most cutting-edge technology like Ulthera, Fraxel and now Coolsculpting helps his patients achieve the look they always dreamed of.

For More Information Contact:
Alexandra Schapiro
Marketing Account Manager
[email protected]
305-918-1886

SOURCE GAINSWave


These press releases may also interest you

at 16:15
Snap Inc. today announced financial results for the quarter ended March 31, 2024. "The value we provide our community and advertising partners has translated into improved financial performance," said Evan Spiegel, CEO. "Our large, growing, and...

at 16:15
Universal Insurance Holdings ("Universal" or the "Company") reported first quarter 2024 results. "It was a strong quarter, including a 29.4% annualized adjusted return on common equity and 35.4% adjusted diluted EPS growth year-over-year," said...

at 16:15
Comfort Systems USA, Inc. (the "Company") today reported results for the quarter ended March 31, 2024. For the quarter ended March 31, 2024, net income was $96.3 million, or $2.69 per diluted share, as compared to $57.2 million, or $1.59 per...

at 16:15
Yelp Inc. , the company that connects people with great local businesses, announced that it will release its financial results for the quarter ended March 31, 2024 after the market closes on Thursday, May 9, 2024. Yelp will issue a press release...

at 16:15
L3Harris Technologies, Inc. reported first quarter 2024 net income attributable to L3Harris of $283 million, or diluted earnings per share (EPS) of $1.48, on first quarter revenue of $5.2 billion. First quarter 2024 non-GAAP1 net income attributable...

at 16:15
PCB Bancorp (the "Company") , the holding company of PCB Bank (the "Bank"), today reported net income of $4.7 million, or $0.33 per diluted common share, for the first quarter of 2024, compared with $5.9 million, or $0.41 per diluted common share,...



News published on and distributed by: